![Quiver Logo](/static/img/logo-icon.png)
![RPHM logo](https://quiver-logos.s3.us-east-2.amazonaws.com/rphm.png)
Reneo Pharmaceuticals, Inc. Common Stock
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RPHM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of RPHM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RPHM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to RPHM
Recent picks made for RPHM stock on CNBC
ETFs with the largest estimated holdings in RPHM
Flights by private jets registered to RPHM
![Quiver Logo](/static/img/logo-icon.png)